BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Pluristem Therapeutics Receives Approval to Commence a Phase I/II Study for Muscle Regeneration in Germany

  August 7, 2012

   · 

  1 min read
• Biotech Bay

  Raptor Pharmaceutical Inc. to Present at Two Upcoming Investor Conferences

  August 7, 2012

   · 

  1 min read
• Business

  Stereotaxis, Inc. Reports 2012 Second Quarter Financial Results

  August 7, 2012

   · 

  1 min read
• Business

  Stereotaxis, Inc. Appoints Dr. Gery Tomassoni M.D. FHRS Chief Medical Officer

  August 7, 2012

   · 

  1 min read
• Drug Development

  Royal Philips Electronics N.V. and Celsion Corporation Announce FDA Clearance to Commence Phase II Study of ThermoDox(R) and MR-Guided HIFU in Bone Cancer

  August 7, 2012

   · 

  5 min read
• Business

  Trius Therapeutics Reports 2012 Second Quarter Financial Results

  August 7, 2012

   · 

  1 min read
• Business

  Spine Pain Management, Inc. Schedules Conference Call to Present Second Quarter 2012 Financial Results and Provide Business Development Update

  August 7, 2012

   · 

  1 min read
• Pharm Country

  Applied DNA Sciences, Inc. Expands Plant and Personnel

  August 7, 2012

   · 

  2 min read
• Business

  Corcept Therapeutics Inc. Announces Second Quarter Results and Corporate Update

  August 7, 2012

   · 

  13 min read
• Business

  Interleukin Genetics Inc. Announces Conference Call to Discuss Second Quarter 2012 Results

  August 7, 2012

   · 

  1 min read